178 related articles for article (PubMed ID: 37604912)
21. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
22. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells.
Xu L; Zhang Y; Gao M; Wang G; Fu Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060
[TBL] [Abstract][Full Text] [Related]
23. The Anti-Non-Small Cell Lung Cancer Cell Activity by a mTOR Kinase Inhibitor PQR620.
Zha JH; Xia YC; Ye CL; Hu Z; Zhang Q; Xiao H; Yu BT; Xu WH; Xu GQ
Front Oncol; 2021; 11():669518. PubMed ID: 34178653
[TBL] [Abstract][Full Text] [Related]
24. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
[TBL] [Abstract][Full Text] [Related]
25. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
26. Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase.
Song K; Dai L; Long X; Wang W; Di W
Sci Rep; 2020 Aug; 10(1):13834. PubMed ID: 32796926
[TBL] [Abstract][Full Text] [Related]
27. α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway.
Saraswati S; Kumar S; Alhaider AA
Mol Cancer; 2013 Nov; 12():147. PubMed ID: 24261856
[TBL] [Abstract][Full Text] [Related]
28. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X
PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective role of sphingolipid rheostat in excitotoxic retinal ganglion cell death.
Nakamura N; Honjo M; Yamagishi R; Kurano M; Yatomi Y; Watanabe S; Aihara M
Exp Eye Res; 2021 Jul; 208():108623. PubMed ID: 34022173
[TBL] [Abstract][Full Text] [Related]
30. Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.
Dayon A; Brizuela L; Martin C; Mazerolles C; Pirot N; Doumerc N; Nogueira L; Golzio M; Teissié J; Serre G; Rischmann P; Malavaud B; Cuvillier O
PLoS One; 2009 Nov; 4(11):e8048. PubMed ID: 19956567
[TBL] [Abstract][Full Text] [Related]
31. Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.
Shao JJ; Peng Y; Wang LM; Wang JK; Chen X
DNA Cell Biol; 2015 Nov; 34(11):669-76. PubMed ID: 26308910
[TBL] [Abstract][Full Text] [Related]
32. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
[TBL] [Abstract][Full Text] [Related]
33. Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
Jiang SJ; Wang S
Tumour Biol; 2015 Sep; 36(10):8177-84. PubMed ID: 25990456
[TBL] [Abstract][Full Text] [Related]
34. Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.
Bandara G; Muñoz-Cano R; Tobío A; Yin Y; Komarow HD; Desai A; Metcalfe DD; Olivera A
Front Immunol; 2018; 9():631. PubMed ID: 29643855
[TBL] [Abstract][Full Text] [Related]
35. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
Ye X; Ruan JW; Huang H; Huang WP; Zhang Y; Zhang F
Aging (Albany NY); 2020 May; 12(10):9489-9499. PubMed ID: 32421688
[TBL] [Abstract][Full Text] [Related]
36. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
37. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
[TBL] [Abstract][Full Text] [Related]
39. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.
Zhang H; Li W; Sun S; Yu S; Zhang M; Zou F
Cell Prolif; 2012 Apr; 45(2):167-75. PubMed ID: 22288844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
